These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiotoxicity of 5-fluorouracil. Alter P; Herzum M; Soufi M; Schaefer JR; Maisch B Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):1-5. PubMed ID: 16529545 [TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of the antiproliferative compound fluorouracil. Becker K; Erckenbrecht JF; Häussinger D; Frieling T Drugs; 1999 Apr; 57(4):475-84. PubMed ID: 10235688 [TBL] [Abstract][Full Text] [Related]
6. Fluoropyrimidine-associated cardiotoxicity: revisited. Saif MW; Shah MM; Shah AR Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247 [TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil-induced coronary thrombosis: A case report and review of the literature. Sorrentino MF; Truesdell AG J Cardiol Cases; 2012 Jul; 6(1):e20-e22. PubMed ID: 30532939 [TBL] [Abstract][Full Text] [Related]
9. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report. Kuropkat C; Griem K; Clark J; Rodriguez ER; Hutchinson J; Taylor SG Am J Clin Oncol; 1999 Oct; 22(5):466-70. PubMed ID: 10521060 [TBL] [Abstract][Full Text] [Related]
10. The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion. Francis N Clin J Oncol Nurs; 2014 Jun; 18(3):360-2. PubMed ID: 24867118 [TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Porta C; Moroni M; Ferrari S; Nastasi G Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887 [TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients. Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449 [TBL] [Abstract][Full Text] [Related]
15. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Jensen SA; Sørensen JB Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875 [TBL] [Abstract][Full Text] [Related]
16. A Case of 5-Fluorouracil-Induced Cardiac Arrest. Ray JC; Cho P; Dragon M; Graham CG J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827 [TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Pai VB; Nahata MC Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823 [TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease. Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310 [TBL] [Abstract][Full Text] [Related]
19. [Cardiotoxicity of 5-fluorouracil: ischemia or myocardial toxicity?]. López Medrano F; Sánchez Muñoz A; Sánchez Sánchez V; Costa Pérez-Herrero JR Rev Clin Esp; 2001 Feb; 201(2):106-7. PubMed ID: 11345600 [No Abstract] [Full Text] [Related]
20. The spectrum of 5-fluorouracil cardiotoxicity. Dalzell JR; Samuel LM Anticancer Drugs; 2009 Jan; 20(1):79-80. PubMed ID: 19353811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]